Browse by Sector

Explore NASDAQ stocks by their primary economic sector.

All NASDAQ Stocks Healthcare 892 Financials 884 Information Technology 517 Industrials 386 Consumer Discretionary 320 Communication Services 200 Consumer Staples 114 Materials 78 Energy 67 Real Estate 64 Utilities 27

Industries in Healthcare

Refine the list using the company’s more specific operating industry.

Biotechnology 471 Pharmaceuticals 159 Healthcare Equipment & Supplies 138 Healthcare Providers & Services 61 Life Sciences Tools & Services 38 Health Care Technology 25
Industry stocks

Biotechnology Stocks on NASDAQ

Compare NASDAQ-listed Biotechnology stocks by fair value, valuation, financial quality, profitability, risk, and market outlook.

INmune Bio Inc (INMB)
Fair Value-1.4% Downside Fair Analyst224.1% Upside Market Cap59.948 M P/E— Yield0.0% HealthFair
  NASDAQ
Innate Pharma SA (IPHA)
Fair Value-3.1% Downside Fair Analyst270.4% Upside Market Cap165 M P/E— Yield0.0% HealthWeak
  NASDAQ
Instil Bio Inc (TIL)
Fair Value17.5% Upside Fair Analyst-1.8% Downside Market Cap48.355 M P/E— Yield0.0% HealthFair
  NASDAQ
Inventiva Sa (IVA)
Fair Value-34.8% Downside Overvalued Analyst307.5% Upside Market Cap829.2 M P/E— Yield0.0% HealthWeak
  NASDAQ
Invivyd Inc (IVVD)
Fair Value21.9% Upside Undervalued Analyst937.3% Upside Market Cap284.1 M P/E— Yield0.0% HealthGood
  NASDAQ
Jade Biosciences Inc (JBIO)
Fair Value-10.2% Downside Fair Analyst199.1% Upside Market Cap1.066 B P/E— Yield0.0% HealthFair
  NASDAQ
Janux Therapeutics Inc (JANX)
Fair Value17.8% Upside Fair Analyst107.4% Upside Market Cap1.068 B P/E— Yield0.0% HealthGood
  NASDAQ
Jasper Therapeutics Inc (JSPR)
Market Cap20.727 M P/E— Yield0.0% HealthWeak
  NASDAQ
Kalaris Therapeutics Inc (KLRS)
Fair Value20.3% Upside Undervalued Analyst477.6% Upside Market Cap77.128 M P/E— Yield0.0% HealthWeak
  NASDAQ
Keros Therapeutics Inc (KROS)
Fair Value28.0% Upside Undervalued Analyst69.1% Upside Market Cap232.6 M P/E— Yield0.0% HealthFair
  NASDAQ
Kodiak Sciences Inc (KOD)
Fair Value-21.5% Downside Overvalued Analyst105.9% Upside Market Cap2.12 B P/E— Yield0.0% HealthFair
  NASDAQ
Korro Bio Inc (KRRO)
Fair Value17.7% Upside Fair Analyst95.4% Upside Market Cap152.3 M P/E— Yield0.0% HealthWeak
  NASDAQ Featured in High-Beta Momentum
Kymera Therapeutics Inc (KYMR)
Fair Value-30.3% Downside Overvalued Analyst13.6% Upside Market Cap10.149 B P/E— Yield0.0% HealthFair
  NASDAQ
Lantern Pharma Inc (LTRN)
Fair Value19.2% Upside Undervalued Market Cap17.386 M P/E— Yield0.0% HealthWeak
  NASDAQ
Legend Biotech Corp (LEGN)
Fair Value30.7% Upside Undervalued Analyst160.1% Upside Market Cap3.612 B P/E— Yield0.0% HealthGood
  NASDAQ
Liminatus Pharma Inc (LIMN)
Fair Value-56.1% Downside Expensive Market Cap5.467 M P/E— Yield0.0% HealthWeak
  NASDAQ
Longeveron LLC (LGVN)
Fair Value51.4% Upside Bargain Market Cap8.672 M P/E— Yield0.0% HealthWeak
  NASDAQ
Lyell Immunopharma Inc (LYEL)
Fair Value6.9% Upside Fair Analyst239.7% Upside Market Cap273.2 M P/E— Yield0.0% HealthWeak
  NASDAQ
MeiraGTx Holdings PLC (MGTX)
Fair Value5.3% Upside Fair Analyst138.3% Upside Market Cap1.186 B P/E15.0x Yield0.0% HealthGreat
  NASDAQ Featured in High-Growth Small-Cap Stocks
Mirum Pharmaceuticals Inc (MIRM)
Fair Value-2.7% Downside Fair Analyst51.2% Upside Market Cap5.934 B P/E— Yield0.0% HealthFair
  NASDAQ
Moderna Inc (MRNA)
Fair Value-45.7% Downside Overvalued Analyst-34.5% Downside Market Cap72.885 B P/E— Yield0.0% HealthGood
  NASDAQ Featured in Top Overvalued Stocks High-Momentum Stocks
Molecular Partners AG ADR (MOLN)
Fair Value-11.4% Downside Fair Analyst147.2% Upside Market Cap158.7 M P/E— Yield0.0% HealthFair
  NASDAQ
Monopar Therapeutics Inc (MNPR)
Fair Value-24.9% Downside Overvalued Analyst32.1% Upside Market Cap648.6 M P/E— Yield0.0% HealthGood
  NASDAQ
Monte Rosa Therapeutics Inc (GLUE)
Fair Value-16.0% Downside Fair Analyst126.2% Upside Market Cap1.075 B P/E— Yield0.0% HealthFair
  NASDAQ
MoonLake Immunotherapeutics (MLTX)
Fair Value29.3% Upside Undervalued Analyst113.3% Upside Market Cap1.138 B P/E— Yield0.0% HealthWeak
  NASDAQ
Nanobiotix (NBTX)
Fair Value-28.1% Downside Overvalued Analyst53.5% Upside Market Cap1.757 B P/E— Yield0.0% HealthFair
  NASDAQ
NewAmsterdam Pharma Company NV (NAMS)
Fair Value-5.7% Downside Fair Analyst119.0% Upside Market Cap2.788 B P/E— Yield0.0% HealthFair
  NASDAQ
NewcelX AG (NCEL)
Fair Value1.5% Upside Fair Analyst657.6% Upside Market Cap17.535 M P/E— Yield0.0% HealthFair
  NASDAQ
NextCure Inc (NXTC)
Fair Value11.1% Upside Fair Analyst286.1% Upside Market Cap23.711 M P/E— Yield0.0% HealthFair
  NASDAQ
Nkarta Inc (NKTX)
Fair Value12.5% Upside Fair Analyst267.2% Upside Market Cap211.3 M P/E— Yield0.0% HealthFair
  NASDAQ
Nurix Therapeutics Inc (NRIX)
Fair Value3.5% Upside Fair Analyst32.2% Upside Market Cap2.664 B P/E— Yield0.0% HealthFair
  NASDAQ
Nuvalent Inc (NUVL)
Market Cap9.834 B P/E—
  NASDAQ
Olema Pharmaceuticals Inc (OLMA)
Fair Value13.4% Upside Fair Analyst277.5% Upside Market Cap843.5 M P/E— Yield0.0% HealthFair
  NASDAQ
Onkure Therapeutics Inc (OKUR)
Fair Value22.6% Upside Undervalued Analyst400.0% Upside Market Cap125.5 M P/E— Yield0.0% HealthFair
  NASDAQ
Oric Pharmaceuticals Inc (ORIC)
Fair Value-29.2% Downside Overvalued Analyst53.1% Upside Market Cap1.399 B P/E— Yield0.0% HealthGood
  NASDAQ
Pasithea Therapeutics Corp (KTTA)
Fair Value24.4% Upside Undervalued Analyst483.7% Upside Market Cap17.178 M P/E— Yield0.0% HealthFair
  NASDAQ
Passage Bio Inc (PASG)
Fair Value15.2% Upside Fair Analyst213.1% Upside Market Cap15.928 M P/E— Yield0.0% HealthFair
  NASDAQ
Pharming Group Nv (PHAR)
Fair Value5.3% Upside Fair Analyst205.1% Upside Market Cap781.5 M P/E84.0x Yield0.0% HealthGreat
  NASDAQ
Pmv Pharmaceuticals Inc (PMVP)
Fair Value26.7% Upside Undervalued Analyst178.1% Upside Market Cap114 M P/E— Yield0.0% HealthFair
  NASDAQ Featured in Bullish Trend Stocks
Praxis Precision Medicines Inc (PRAX)
Fair Value-22.4% Downside Overvalued Analyst112.4% Upside Market Cap8.394 B P/E— Yield0.0% HealthFair
  NASDAQ
Precision BioSciences Inc (DTIL)
Fair Value-20.3% Downside Overvalued Analyst308.9% Upside Market Cap198.5 M P/E— Yield0.0% HealthFair
  NASDAQ
Prelude Therapeutics Inc (PRLD)
Fair Value12.9% Upside Fair Analyst89.7% Upside Market Cap499.5 M P/E— Yield0.0% HealthFair
  NASDAQ Featured in Low-Float Small-Cap Momentum Stocks High-Growth Small-Cap Stocks
Propanc Biopharma Inc (PPCB)
Fair Value6.1% Upside Fair Market Cap1.483 M P/E— Yield0.0%
  NASDAQ
Quince Therapeutics Inc (QNCX)
Fair Value9.0% Upside Fair Analyst140.6% Upside Market Cap31.885 M P/E— Yield0.0% HealthFair
  NASDAQ
Rallybio Corp (RLYB)
Fair Value-12.9% Downside Fair Analyst-52.7% Downside Market Cap89.854 M P/E2.0x Yield0.0% HealthGreat
  NASDAQ
Recursion Pharmaceuticals Inc (RXRX)
Fair Value-2.1% Downside Fair Analyst78.2% Upside Market Cap2.172 B P/E— Yield0.0% HealthFair
  NASDAQ
Relay Therapeutics Inc (RLAY)
Fair Value-30.6% Downside Overvalued Analyst39.9% Upside Market Cap4.24 B P/E— Yield0.0% HealthFair
  NASDAQ
RenovoRx Inc (RNXT)
Fair Value11.2% Upside Fair Analyst319.1% Upside Market Cap76.72 M P/E— Yield0.0% HealthFair
  NASDAQ
Replimune Group Inc (REPL)
Fair Value-23.7% Downside Overvalued Analyst44.8% Upside Market Cap1.269 B P/E— Yield0.0% HealthWeak
  NASDAQ
Revolution Medicines Inc (RVMD)
Fair Value-15.5% Downside Fair Analyst31.3% Upside Market Cap41.337 B P/E— Yield0.0% HealthFair
  NASDAQ
Explore listed stocks on NASDAQ with company information and fair value data.